MeSH tree: D12.776.543
Every year in the U.S., about a million people are treated at emergency rooms for traumatic brain injuries (TBIs), and about 50,000 people die from the injuries or complicating factors, according to the International Brain ...
Apr 14, 2026
0
2
A study by investigators at Mass General Brigham has found that a blood test of plasma phosphorylated tau 217 (pTau217), an Alzheimer's disease biomarker, can predict the progression of amyloid PET scan changes and cognitive ...
Apr 14, 2026
0
279
A new study has found that combining the current medications for Alzheimer's disease with small molecules derived from micronutrients found in grapes, berries, peanuts and turmeric is a safer and more effective way to treat ...
Apr 11, 2026
0
49
A research team led by Professor Jiwon Um from the Center for Synapse Diversity and Specificity at DGIST has discovered a mechanism by which somatostatin, a brain neurotransmitter, directly regulates brain immune cells to ...
Apr 9, 2026
0
11
A research group at Uppsala University has demonstrated that a new method for PET imaging of Alzheimer's disease is effective. The study was conducted in collaboration between the Department of Public Health and Caring Sciences, ...
Apr 8, 2026
0
7
Antibody therapeutics are laboratory-made proteins designed to work like the body's natural antibodies. They are widely used to treat diseases such as cancer by binding to specific targets, including cancer cells or inflammatory ...
Apr 8, 2026
0
9
The application of CAR immunotherapies to neurodegenerative diseases is limited by major challenges due to the complex nature of these pathologies and the heterogeneity of harmful molecules to be treated. Nonetheless, and ...
Apr 8, 2026
0
3
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new blood-based biomarker that can help identify and characterize asymptomatic people with Lynch Syndrome (LS) who are more susceptible to ...
Apr 7, 2026
0
10
A new daily pill to help with weight loss has been approved by the U.S. Food and Drug Administration (FDA), and it moved through review faster than most drugs in recent years.
Apr 2, 2026
0
8
Alain Chariot's team has just published a study in EMBO Molecular Medicine shedding light on the unexpected role of the Stard7 protein in the development of intestinal cancers. Long regarded as a simple lipid transporter, ...
Apr 2, 2026
0
6
